Skip to main content

Cti Biopharma Corp

CTICDelisted Jun 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0000891293

Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.

13F holders, Q2 2021

Institutional positions in Cti Biopharma Corp as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
−5 vs. Q1 2021
Shares held
53.2M
+9.91M (+22.9%) vs. Q1 2021
Total value
$133.1M
+$7.01M (+5.6%) vs. Q1 2021
New holders
5
18 more added
Sold out
10
11 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 50 institutions
Q1 2021: 55 institutionsQ2 2021: 50 institutionsQ3 2021: 56 institutionsQ4 2021: 63 institutionsQ1 2022: 92 institutionsQ2 2022: 119 institutionsQ3 2022: 133 institutionsQ4 2022: 145 institutionsQ1 2023: 133 institutionsQ2 2023: 2 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2021: $133.1M
Q1 2021: $126.1MQ2 2021: $133.1MQ3 2021: $159.6MQ4 2021: $118.3MQ1 2022: $344.9MQ2 2022: $510.1MQ3 2022: $554.7MQ4 2022: $619.8MQ1 2023: $475.2MQ2 2023: $474.2KQ3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CTIC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20232$474.2K
Q1 2023133$475.2M
Q4 2022145$619.8M
Q3 2022133$554.7M
Q2 2022119$510.1M
Q1 202292$344.9M
Q4 202163$118.3M
Q3 202156$159.6M
Q2 202150$133.1M
Q1 202155$126.1M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Cti Biopharma Corp; share changes are against Q1 2021.

Institutions holding CTIC in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc8,929,690$22.3M0.84%+2,000,000+28.9%Added
Stonepine Capital Management, LLC7,632,530$19.1M9.98%+4,339,111+131.8%Added
OrbiMed Advisors LLC7,520,600$18.8M0.19%00.0%Unchanged
NEA Management Company, LLC7,140,450$17.9M0.23%00.0%Unchanged
Altium Capital Management LP3,678,677$9.20M2.13%+3,089,685+524.6%Added
Vanguard Group Inc3,666,204$9.16M0.00%+620,892+20.4%Added
Renaissance Technologies LLC2,438,433$6.10M0.01%+827,620+51.4%Added
Caxton Corp2,314,533$5.79M3.96%−200,114−8.0%Reduced
Ghost Tree Capital, LLC1,600,000$4.00M1.25%+850,000+113.3%Added
Two Sigma Investments, LP1,271,819$3.18M0.01%+572,907+82.0%Added
Two Sigma Advisers, LP1,172,213$2.93M0.01%+652,000+125.3%Added
Morgan Stanley1,065,781$2.66M0.00%−402,213−27.4%Reduced
Verition Fund Management LLC978,679$2.45M0.04%−133,001−12.0%Reduced
Deutsche Bank AG970,435$2.43M0.00%+970,429+16,173,816.7%Added
BlackRock Inc.897,051$2.24M0.00%−33,559−3.6%Reduced
Geode Capital Management, LLC589,150$1.47M0.00%+106,502+22.1%Added
Millennium Management LLC284,216$711.0K0.00%−151,384−34.8%Reduced
Sofinnova Investments, Inc.171,619$429.0K0.03%+171,619New
State Street Corp165,414$414.0K0.00%+144,262+682.0%Added
Northern Trust Corp126,259$316.0K0.00%+25,506+25.3%Added
Schonfeld Strategic Advisors LLC77,000$193.0K0.00%+36,474+90.0%Added
Blair William & Co76,198$190.0K0.00%00.0%Unchanged
Squarepoint Ops LLC72,325$181.0K0.00%−125,186−63.4%Reduced
Knott David M60,000$150.0K0.06%+40,000+200.0%Added
Occudo Quantitative Strategies LP55,555$139.0K0.02%−4,993−8.2%Reduced
Cubist Systematic Strategies, LLC51,287$128.0K0.00%+26,266+105.0%Added
Goldman Sachs Group Inc41,558$104.0K0.00%+41,558New
Price T Rowe Associates Inc32,700$82.0K0.00%00.0%Unchanged
KBC Group NV29,947$75.0K0.00%+29,947New
Bank of New York Mellon Corp26,332$66.0K0.00%00.0%Unchanged
Quantitative Systematic Strategies LLC25,686$64.0K0.02%−323−1.2%Reduced
Charles Schwab Investment Management Inc20,000$50.0K0.00%00.0%Unchanged
AQR Capital Management LLC15,365$38.0K0.00%00.0%Unchanged
Victory Capital Management Inc13,523$34.0K0.00%+2,366+21.2%Added
Advisor Group Holdings, Inc.10,681$27.0K0.00%00.0%Unchanged
JPMorgan Chase & Co9,539$24.0K0.00%+1,938+25.5%Added
UBS Group AG6,747$17.0K0.00%−3,224−32.3%Reduced
Barclays PLC5,605$14.0K0.00%−59,349−91.4%Reduced
Fieldpoint Private Securities, LLC1,000$3.00K0.00%00.0%Unchanged
Wells Fargo & Company543$1.00K0.00%+166+44.0%Added
O'Shaughnessy Asset Management, LLC406$1.00K0.00%00.0%Unchanged
Citigroup Inc3$00.00%−26,560−100.0%Reduced
Sound Income Strategies, LLC33$00.00%00.0%Unchanged
First Manhattan Co33$00.00%00.0%Unchanged
Harbour Investments, Inc.9$00.00%00.0%Unchanged
Royal Bank of Canada43$00.00%00.0%Unchanged
Ancora Advisors, LLC1$00.00%00.0%Unchanged
Syverson Strege & Co3$00.00%00.0%Unchanged
Bank of America Corp33$00.00%+33New
Bedel Financial Consulting, Inc.10$00.00%+10New
Consonance Capital Management LP0$00.00%−2,512,800−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−263,140−100.0%Sold out
Citadel Advisors LLC0$00.00%−211,206−100.0%Sold out
HRT Financial LP0$00.00%−194,242−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−189,516−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−41,593−100.0%Sold out
LMR Partners LLP0$00.00%−37,769−100.0%Sold out
California Public Employees Retirement System0$00.00%−28,400−100.0%Sold out
Credit Suisse AG0$00.00%−14,117−100.0%Sold out
Simplex Trading, LLC0$00.00%−6,688−100.0%Sold out